Health
Singapore develops potential antibody treatment for yellow fever – BSA bureau
TY014 is developed by Rapid Response Strategy and can be extended to treat other infectious disease indications
TY014 is developed by Rapid Response Strategy and can be extended to treat other infectious disease indications
Researchers from Antimicrobial Resistance (AMR), an interdisciplinary group at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have developed TY014, a potential antibody treatment for yellow fever. SMART AMR collaborated with researchers from Massachusetts Institute of Technology (MIT), and local institutions such as the Singapore Ge…
-
General24 hours agoAustralia’s Myanmar community mourns earthquake losses
-
General22 hours agoPeter Dutton partially walks back public service work-from-home vow
-
Noosa News20 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News23 hours agoAustralian growers expect to benefit from US tariffs as Trump’s trade war angers markets